Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry

Histochemistry and Cell Biology

Volumn 110, Issue 1, 1998, Pages 27-32

  Hildenbrand, Ralf ^a   Glienke, Wolfgang ^a   Magdolen, Viktor ^b   Graeff, Henner ^b   Stutte, Hans Jochen ^a   Schmitt, Manfred ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ARTICLE; BREAST CANCER; CANCER INVASION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DENSITY; TECHNIQUE; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CHICKENS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MIDDLE AGED; OLIGONUCLEOTIDE PROBES; RECEPTORS, CELL SURFACE; RNA, MESSENGER; URINARY PLASMINOGEN ACTIVATOR;

GALLUS GALLUS;

EID: 0031780855     PISSN: 09486143     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004180050261     Document Type: Article

References (24)

1. Andreasen PA, Kjoller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 72:1-22
2. Bianchi E, Cohen RL, Thor AT, Todd III RF, Mizukami IF, Lawrence DA, Ljung BM, Shumann MA, Smith HS (1994) The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54:861-866
3. Carriero MV, Franco P, Del Vecchio S, Massa O, Botti G, D'Aiuto G, Stoppeli MP, Salvatore M (1994) Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies. Cancer Res 54:5445-5454
4. 2-macroglobulin receptor in human breast carcinomas. Int J Cancer 66:441-452
5. Cordell IL, Falini B, Erber WN, Gosh AK, Abdulaziz, Z, Macdonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229
6. Dano K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C (1994) The urokinase receptor: protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8:189-203
7. Del Vecchio S, Stoppelli MP, Carriero MV, Fonti R, Massa O, Li PY, Botti G, Cerra M, D'Aiuto G, Esposito G, Salvatore M (1993) Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res 53: 3198-3206
8. De Vries TJ, Quax PHA, Denijn M, Verrijp KN, Verheijen JH, Verspaget HW, Weidle UH, Ruiter DJ, Muijen GNP van (1994) Plasminogen activators, their inhibitors and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70-81
9. Duggan C, Maguire T, McDermott E, O'Higgins N, Fennelly JJ, Duffy MJ (1995) Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 61:597-600
10. Grondahl-Hansen J, Peters HA, Putten WLJ van, Look MP, Pappot H, Ronne E, Dano K, Klijn JGM, Brünner N, Foekens JA (1995) Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer. Clin Cancer Res 1:1079-1087
11. Hell K, Pringle JH, Hansmann ML, Lorenzen J, Colloby P, Lauder I, Fischer R (1993) Demonstration of light chain mRNA in Hodgkin's disease. J Pathol 137-143
12. Hell K, Lorenzen J, Fischer R, Hansmann ML (1995) Hodgkin cells accumulate mRNA for bcl-2. Lab Invest 73:492-496
13. Hildenbrand R, Dilger I, Horlin A, Stutte HJ (1995) Urokinase and macrophages in tumor angiogenesis. Br J Cancer 72:818-823
14. Howell AL, Memoli VA, Rousseau SM, Zacharski LR (1995) Detection of urokinase receptor (uPA-R) on human breast and colon cancer cells using a panel of anti-uPA-R mAb. In: Schlossman SF et al (eds) Leucocyte typing V. Oxford University Press, Oxford, pp 950-952
15. Jankun J, Merrick HW, Goldblatt PJ (1993) Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem 53:135-144
16. Kim SJ, Shiba E, Taguchi T, Waranabe T, Tanji Y, Kimoto Y, Izukura M, Takai S (1997) Urokinase type plasminogen activator receptor is a novel prognostic factor in breast cancer. Anticancer Res 17:1373-1378
17. Lawrence DA, Cohen RL (1995) Characterization of anti-urokinase receptor antibodies using purified receptor protein. In: Schlossman SF et al (eds) Leucocyte typing V. Oxford University Press, Oxford, pp 948-950
18. Luther T, Magdolen V, Albrecht S, Kasper M, Riemer C, Kessler H, Graeff H, Müller M, Schmitt M (1997) Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissue. Am J Pathol 150:1231-1244
19. Magdolen V, Rettenberger P, Lopens A, Oi H, Lottspeich F, Kellermann J, Creutzburg S, Goretzki L, Weidle U, Wilhelm O, Schmitt M, Graeff H (1995) Expression of the human uPA receptor (uPA-R) in E. coli and CHO cells: purification of the recombinant proteins and generation of polyclonal antibodies in chicken. Electrophoresis 16:813-816
20. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F, Dano K (1991) Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinoma. Am J Pathol 138:1059-1067
21. Pyke C, Graem N, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Brpnner N, Dano K (1993) Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911-1915
22. Pyke C, Ralfkiaer E, Ronne E, Hoyer-Hansen G, Kirkeby L, Dano K (1994) Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 24:131-138
23. Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höfler H, Jänicke F, Greaff H (1997) Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost 78:285-296
24. Todd III RF, Barnathan ES, Bohuslav J, Chapman HA, Cohen RL, Felez J, Howell A, Johnson JG, Knapp W, Kramer M, Miles LA, Nykjaer A, Ralfkiaer E, Schüren E (1995) CD87 cluster workshop report. In: Schlossman SF et al (eds) Leucocyte typing V. Oxford University Press, Oxford, pp 932-939